230 related articles for article (PubMed ID: 20890892)
1. Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice.
Ko KS; Tomasi ML; Iglesias-Ara A; French BA; French SW; Ramani K; Lozano JJ; Oh P; He L; Stiles BL; Li TW; Yang H; Martínez-Chantar ML; Mato JM; Lu SC
Hepatology; 2010 Dec; 52(6):2096-108. PubMed ID: 20890892
[TBL] [Abstract][Full Text] [Related]
2. Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells.
Fan W; Yang H; Liu T; Wang J; Li TW; Mavila N; Tang Y; Yang J; Peng H; Tu J; Annamalai A; Noureddin M; Krishnan A; Gores GJ; Martínez-Chantar ML; Mato JM; Lu SC
Hepatology; 2017 Apr; 65(4):1249-1266. PubMed ID: 27981602
[TBL] [Abstract][Full Text] [Related]
3. Prohibitin 1 Regulates the H19-Igf2 Axis and Proliferation in Hepatocytes.
Ramani K; Mavila N; Ko KS; Mato JM; Lu SC
J Biol Chem; 2016 Nov; 291(46):24148-24159. PubMed ID: 27687727
[TBL] [Abstract][Full Text] [Related]
4. Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis.
Fan W; Cao D; Yang B; Wang J; Li X; Kitka D; Li TWH; You S; Shiao S; Gangi A; Posadas E; Di Vizio D; Tomasi ML; Seki E; Mato JM; Yang H; Lu SC
J Hepatol; 2024 Mar; 80(3):443-453. PubMed ID: 38086446
[TBL] [Abstract][Full Text] [Related]
5. Prohibitin 1 Acts As a Negative Regulator of Wingless/Integrated-Beta-Catenin Signaling in Murine Liver and Human Liver Cancer Cells.
Mavila N; Tang Y; Berlind J; Ramani K; Wang J; Mato JM; Lu SC
Hepatol Commun; 2018 Dec; 2(12):1583-1600. PubMed ID: 30556043
[TBL] [Abstract][Full Text] [Related]
6. The mitochondrial chaperone Prohibitin 1 negatively regulates interleukin-8 in human liver cancers.
Yang JW; Murray B; Barbier-Torres L; Liu T; Liu Z; Yang H; Fan W; Wang J; Li Y; Seki E; Mato JM; Lu SC
J Biol Chem; 2019 Feb; 294(6):1984-1996. PubMed ID: 30523154
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
8. Prohibitin 1 inhibits cell proliferation and induces apoptosis
Shi JJ; Wang YK; Wang MQ; Deng J; Gao N; Li M; Li YP; Zhang X; Jia XL; Liu XT; Dang SS; Wang WJ
World J Gastrointest Oncol; 2024 Feb; 16(2):398-413. PubMed ID: 38425403
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1.
Barbier-Torres L; Beraza N; Fernández-Tussy P; Lopitz-Otsoa F; Fernández-Ramos D; Zubiete-Franco I; Varela-Rey M; Delgado TC; Gutiérrez V; Anguita J; Pares A; Banales JM; Villa E; Caballería J; Alvarez L; Lu SC; Mato JM; Martínez-Chantar ML
Hepatology; 2015 Oct; 62(4):1237-48. PubMed ID: 26109312
[TBL] [Abstract][Full Text] [Related]
11. Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis.
Martínez-López N; Varela-Rey M; Fernández-Ramos D; Woodhoo A; Vázquez-Chantada M; Embade N; Espinosa-Hevia L; Bustamante FJ; Parada LA; Rodriguez MS; Lu SC; Mato JM; Martínez-Chantar ML
Hepatology; 2010 Nov; 52(5):1621-31. PubMed ID: 20815019
[TBL] [Abstract][Full Text] [Related]
12. Can Prohibitin 1 be a Safeguard against liver disease?
Xia L; Liu Y; Zhang S; Yang Y; Zhou Z; Tu J
Ann Hepatol; 2019; 18(6):790-795. PubMed ID: 31558419
[TBL] [Abstract][Full Text] [Related]
13. Targeted deletion of ER chaperone GRP94 in the liver results in injury, repopulation of GRP94-positive hepatocytes, and spontaneous hepatocellular carcinoma development in aged mice.
Chen WT; Ha D; Kanel G; Lee AS
Neoplasia; 2014 Aug; 16(8):617-26. PubMed ID: 25220589
[TBL] [Abstract][Full Text] [Related]
14. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
15. Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.
Frau M; Tomasi ML; Simile MM; Demartis MI; Salis F; Latte G; Calvisi DF; Seddaiu MA; Daino L; Feo CF; Brozzetti S; Solinas G; Yamashita S; Ushijima T; Feo F; Pascale RM
Hepatology; 2012 Jul; 56(1):165-75. PubMed ID: 22318685
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.
Katzenellenbogen M; Mizrahi L; Pappo O; Klopstock N; Olam D; Jacob-Hirsch J; Amariglio N; Rechavi G; Domany E; Galun E; Goldenberg D
Mol Cancer Res; 2007 Nov; 5(11):1159-70. PubMed ID: 18025261
[TBL] [Abstract][Full Text] [Related]
17. S-adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcinogenesis.
Tomasi ML; Iglesias-Ara A; Yang H; Ramani K; Feo F; Pascale MR; Martínez-Chantar ML; Mato JM; Lu SC
Gastroenterology; 2009 Mar; 136(3):1025-36. PubMed ID: 18983843
[TBL] [Abstract][Full Text] [Related]
18. RNA-Seq Reveals Different Gene Expression in Liver-Specific Prohibitin 1 Knock-Out Mice.
Lee K; Yu H; Shouse S; Kong B; Lee J; Lee SH; Ko KS
Front Physiol; 2021; 12():717911. PubMed ID: 34539442
[TBL] [Abstract][Full Text] [Related]
19. The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma.
Gamaev L; Mizrahi L; Friehmann T; Rosenberg N; Pappo O; Olam D; Zeira E; Bahar Halpern K; Caruso S; Zucman-Rossi J; Axelrod JH; Galun E; Goldenberg DS
Oncogene; 2021 Jan; 40(1):127-139. PubMed ID: 33093654
[TBL] [Abstract][Full Text] [Related]
20. S-adenosylmethionine inhibits la ribonucleoprotein domain family member 1 in murine liver and human liver cancer cells.
Ramani K; Robinson AE; Berlind J; Fan W; Abeynayake A; Binek A; Barbier-Torres L; Noureddin M; Nissen NN; Yildirim Z; Erbay E; Mato JM; Van Eyk JE; Lu SC
Hepatology; 2022 Feb; 75(2):280-296. PubMed ID: 34449924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
